Every recall we track for Central Admixture Pharmacy Services, Inc. — 347 in all — plus the complaints and injury reports the public filed about them.
Central Admixture Pharmacy Services recalls pediatric TPN bags with incorrect formulation. Patients may face health risks from improper nutrition mixtures. Contact for details.
Central Admixture Pharmacy Services recalls pediatric TPN bags that lack copper and famotidine as labeled, potentially causing unsafe nutrition delivery.
Central Admixture Pharmacy Services recalls phenylephrine IV solution (NDC 71285-6092-1) due to particulate matter. Affected lots expire March 2025. Discard immediately if you have these lots.
Central Admixture Pharmacy Services recalls hydro morphone syringes due to lack of sterility assurance. Affected lots expire 10/2023 and 10/8/2023. No remedy specified in official notice.
Central Admixture Pharmacy Services recalls fentanyl injection vials with potential lack of sterility. Affected lots expire by October 2023. Consumers should contact the manufacturer for details.
Central Admixture Pharmacy Services recalls specific rocuronium syringes (NDC 71286-6010-1) due to lack of sterility assurance. Affected lots expire by October 2023. Contact for remedy details.
Central Admixture Pharmacy Services recalls specific hydrocodone syringes (NDC 71286-2012-1) due to lack of sterility assurance. Affected units have lot numbers ending in 17-275339 through 17-276027 with expiration dates through October 2023.
CAPS recalls lidocaine 2% 5mL syringes due to lack of sterility assurance. Affected lots expire 10/2023. Stop using immediately to avoid infection risks.
Central Admixture Pharmacy Services recalls hydro morphine syringes (NDC 71286-2012-1) with potential sterility issues. Affected units may cause infection if used.
Central Admixture Pharmacy Services recalls phenylephrine in 0.9% sodium chloride syringes (NDC 71286-6009-1) due to lack of sterility assurance. Affected lots expire through October 2023.
Central Admixture Pharmacy Services recalls fentanyl injection vials due to lack of sterility assurance. Affected lots expire by October 2023. No remedy specified in official notice.
Central Admixture Pharmacy Services recalls fentanyl 250mL bags with specific lot numbers due to lack of sterility assurance. This could lead to infections if used improperly.
Central Admixture Pharmacy Services recalls fentanyl 2 mcg/mL and bupivacaine 0.0625% solution in 250mL due to lack of sterility assurance. This product is for medical use only and must be discarded if affected.
Central Admixture Pharmacy Services recalls hydro morphone syringes with specific lot numbers due to lack of sterility assurance. This could lead to infections if used improperly.
Central Admixture Pharmacy Services recalls fentanyl 100mL bags due to lack of sterility assurance. This could lead to infections if used improperly. Affected units have specific NDC and lot numbers.
Central Admixture Pharmacy Services recalls midazolam in dextrose 5% solution due to lack of sterility assurance. Affected lots expire by October 2023. Contact for details.
Central Admixture Pharmacy Services recalls hydrocodone syringes (NDC 71286-2011-1) due to lack of sterility assurance. Affected lots expire by October 2023. Consumers should contact the manufacturer for details.
CAPS recalls specific lots of succinylcholine 200mg/10mL syringes due to lack of sterility assurance. Affected products may cause infection if used improperly.
CAPS recalls ketamine in 0.9% sodium chloride syringes due to lack of sterility assurance. Affected lots expire by October 2023. Consumers should check NDC and lot numbers for affected products.
Central Admixture Pharmacy Services recalls fentanyl 1.5 mcg/mL and bupivacaine 0.125% in 50mL syringes due to lack of sterility assurance. This could lead to infections if used improperly.
Central Admixture Pharmacy Services recalls fentanyl syringes due to lack of sterility assurance. This may cause infections if used improperly. Affected products have specific lot numbers and expiration dates.
Central Admixture Pharmacy Services recalls fentanyl syringes due to lack of sterility assurance. These syringes may cause infections if used improperly. Contact the manufacturer for details.
Central Admixture Pharmacy Services recalls phenylephrine syringes with specific lot numbers due to lack of sterility assurance. Consumers should contact the manufacturer for details on affected products and remedies.
Central Admixture Pharmacy Services recalls fentanyl syringes due to lack of sterility assurance. Affected products have specific NDC and expiration dates. Consumers should contact the manufacturer for details.
Central Admixture Pharmacy Services recalls fentanyl syringes (NDC 71286-2003-7) with specific lot numbers due to lack of sterility assurance. This could lead to infections if used improperly.
Central Admixture Pharmacy Services recalls hydro morphine syringes with lot numbers 17-275680, 17-275945, and 17-276094 due to lack of sterility assurance. These syringes are for prescription use only in central pharmacy settings.
Central Admixture Pharmacy Services recalls fentanyl 100mL bags (NDC 71286-2003-5) with lot 17-275322 due to lack of sterility assurance. No remedy specified in recall notice.
Central Admixture Pharmacy Services recalls fentanyl syringes due to lack of sterility assurance. This affects repackaged products with specific NDC and lot numbers. Consumers should contact the manufacturer for details.
Central Admixture Pharmacy Services recalls neonatal TPN starter bags due to lack of sterility assurance from sanitization cycles. This affects specific lot numbers and requires immediate action to prevent infection risks.
Central Admixture Pharmacy Services recalls epinephrine IV bags (NDC 72196-8093-1) with lot #36-260047 due to insufficient sanitization validation. This could lead to infections if used in medical procedures.
Central Admixture Pharmacy Services recalls low potassium cardioplegia solution due to lack of sterility assurance. This product may cause infections if used improperly. Affected units have specific lot numbers and expiration dates.
Central Admixture Pharmacy Services recalls dilTIAZem 125mg/125mL IV bags due to lack of validation data for sanitization cycles. This poses a risk of contamination during IV administration.
Central Admixture Pharmacy Services recalls Cardioplegia Solution (500mL) due to lack of validation for sanitization cycles. This could lead to contamination. Check NDC 72196-0105-1 and lot 36-262516.
Central Admixture Pharmacy Services recalls Cardioplegia Solution (NDC 72196-0103-1) due to lack of sterility assurance from sanitization cycles. Affected lots expire 8/21/2023 to 8/28/2023. Contact for details.
Central Admixture Pharmacy Services recalls specific cardioplegia solutions due to unvalidated sanitization cycles risking contamination.
Central Admixture Pharmacy Services recalls IV bags containing phenylephrine that may not be sterile due to insufficient sanitization validation. Affected units have NDC 72196-6092-1 and lot 36-260036. Stop using immediately.
Central Admixture Pharmacy Services recalls neonatal TPN starter bags with potential lack of sterility due to unvalidated sanitization cycles. Affected units have specific NDC and lot numbers. Contact for remedy details.
Central Admixture Pharmacy Services recalls repackaged rocuronium 50mg/5mL syringes due to unvalidated sanitization cycles. Affected lots expire 10/11/2023. Consumers should contact CAPS for details.
Central Admixture Pharmacy Services recalls phenylephrine syringes (NDC 72196-6009-1) with specific lot numbers due to lack of validation data for sanitization cycles, posing a sterility risk.
Central Admixture Pharmacy Services recalls oxyTOCIN IV bags due to unvalidated sanitization cycles risking contamination. Affected units have NDC 72196-8069-1, Lot 36-260050, expiring 10/3/2023.
Central Admixture Pharmacy Services recalls high-potassium cardioplegia solution (NDC 72196-0100-1) due to lack of sterility assurance from sanitization cycles. Affected lots expire 8/25/2023 and 8/27/2023.
Central Admixture Pharmacy Services recalls vancomycin solution due to lack of validation data for sanitization cycles. This affects specific lot numbers and expiration dates. Contact for remedy details.
Central Admixture Pharmacy Services recalls neonatal TPN starter bags due to lack of sterility assurance from sanitization cycles. This affects specific IV bags used in hospitals for newborns.
Central Admixture Pharmacy Services recalls phenylephrine IV bags (NDC 72196-6058-1) with lot numbers 36-260033 and 36-260034 due to insufficient sanitization validation. These bags are for IV use only and may not be sterile, posing a risk of infection.
Central Admixture Pharmacy Services recalls phenylephrine IV bags (NDC 72196-7025-1) with potential sterility issues. This is for medical use only, not for home patients.
Central Admixture Pharmacy Services recalls neonatal TPN starter bags with low calcium and heparin due to lack of sterility assurance. Affected units have specific NDC and lot numbers. Contact for remedy details.
Central Admixture Pharmacy Services recalls Cardioplegia Solution (500mL) due to lack of sterility assurance. This product is for medical use only and may cause infections if not properly sterilized.
Central Admixture Pharmacy Services recalls neonatal TPN starter bags with low calcium and heparin due to lack of sterility assurance. Patients may face infection risks from improper sanitization cycles.